Methods of treating chronic hepatitis b
AssigneeGlaxoSmithKline Intellectual Property Development Limited
InventorsLeigh Michael FELTON, Susan Amanda DIXON, Robert Conrad ELSTON, Dickens THEODORE
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods for treating a human with chronic hepatitis B. The methods comprise administering to a human in need thereof a therapeutically effective amount of antisense oligonucleotide (ASO) (e.g. bepirovirsen) and a therapeutically effective amount of interferon, wherein the human has a HBsAg baseline level of not greater than a threshold level. The present disclosure further relates to specific dosing regimens.
Claims41
A method for treating chronic hepatitis B in a human in need thereof, the method comprising administering to the human a therapeutically effective amount of an antisense oligonucleotide (ASO) and a therapeutically effective amount of interferon, wherein the human has a HBsAg baseline level of not greater than a threshold level.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.